Gilead Sciences Inc
SWB:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
SWB:GIS
|
US |
|
E
|
Engie SA
XBER:GZF
|
FR |
|
B
|
Brady Corp
SWB:BRV
|
US |
|
C
|
Cerence Inc
F:0S6
|
US |
|
V
|
VinFast Auto Ltd
NASDAQ:VFS
|
SG |
|
L
|
Life Healthcare Group Holdings Ltd
SWB:L53
|
ZA |
|
L
|
Laboratory Corporation of America Holdings
SWB:LAB
|
US |
|
FVCBankcorp Inc
F:I29
|
US |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
Airtel Africa PLC
OTC:AARTY
|
UK |
|
B
|
Balchem Corp
XBER:BL9B
|
US |
|
Galapagos NV
AEX:GLPG
|
BE |
|
T
|
Toppan Inc
XBER:TPX
|
JP |
|
Agilysys Inc
NASDAQ:AGYS
|
US |
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
AltaGas Ltd
TSX:ALA
|
CA |
|
ID Logistics SAS
PAR:IDL
|
FR |
|
APA Group
ASX:APA
|
AU |
|
Hong Kong and China Gas Co Ltd
HKEX:3
|
HK |
|
Red Robin Gourmet Burgers Inc
NASDAQ:RRGB
|
US |
|
CBRE Group Inc
NYSE:CBRE
|
US |
|
Naturgy Energy Group SA
MAD:NTGY
|
ES |
|
CCR SA
BOVESPA:CCRO3
|
BR |
|
T
|
Tokyo Gas Co Ltd
TSE:9531
|
JP |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 138.13 EUR with a low forecast of 105.93 EUR and a high forecast of 161.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
138.13
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 138.13 EUR with a low forecast of 105.93 EUR and a high forecast of 161.15 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 10%.
